Misonix Inc (NASDAQ:MSON) Stock Price Up as Sentiment Improves

Misonix, Inc. (NASDAQ:MSON) Logo

Sentiment for Misonix Inc (NASDAQ:MSON)

Misonix Inc (NASDAQ:MSON) institutional sentiment increased to 2.67 in 2019 Q2. Its up 0.54, from 2.13 in 2019Q1. The ratio has increased, as 32 active investment managers opened new and increased equity positions, while 12 sold and trimmed equity positions in Misonix Inc. The active investment managers in our partner’s database now own: 2.62 million shares, up from 1.72 million shares in 2019Q1. Also, the number of active investment managers holding Misonix Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 5 Reduced: 7 Increased: 12 New Position: 20.

Misonix, Inc., together with its subsidiaries, designs, develops, makes, and markets therapeutic ultrasonic medical devices in the United States and internationally. The company has market cap of $164.42 million. The firm offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells, as well as other medical devices. It currently has negative earnings. The Company’s products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wounds, and maxillo-facial applications.

The stock increased 4.28% or $0.7 during the last trading session, reaching $17.04. About 45,080 shares traded. Misonix, Inc. (NASDAQ:MSON) has risen 40.83% since October 12, 2018 and is uptrending. It has outperformed by 40.83% the S&P500.

Pura Vida Investments Llc holds 0.69% of its portfolio in Misonix, Inc. for 93,045 shares. Eam Investors Llc owns 84,380 shares or 0.52% of their US portfolio. Moreover, Essex Investment Management Co Llc has 0.36% invested in the company for 102,733 shares. The United Kingdom-based River & Mercantile Asset Management Llp has invested 0.36% in the stock. Manatuck Hill Partners Llc, a Connecticut-based fund reported 11,900 shares.

Since January 1, 0001, it had 3 insider buys, and 0 selling transactions for $24,436 activity.

More notable recent Misonix, Inc. (NASDAQ:MSON) news were published by: Finance.Yahoo.com which released: “The Chart Industries (NASDAQ:GTLS) Share Price Has Gained 196%, So Why Not Pay It Some Attention? – Yahoo Finance” on June 15, 2019, also Benzinga.com with their article: “The Daily Biotech Pulse: Regeneron’s Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering – Benzinga” published on August 14, 2019, Globenewswire.com published: “Misonix Cites Significant Healthcare Cost Savings Using BoneScalpel in Bone Removal Procedures – GlobeNewswire” on October 25, 2017. More interesting news about Misonix, Inc. (NASDAQ:MSON) were released by: Streetinsider.com and their article: “Form 8-K12B MISONIX INC For: Sep 27 – StreetInsider.com” published on September 27, 2019 as well as Seekingalpha.com‘s news article titled: “MISONIX, Inc. 2018 Q1 – Results – Earnings Call Slides – Seeking Alpha” with publication date: November 08, 2017.

Misonix, Inc. (NASDAQ:MSON) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.